10/31/2025Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...

10/28/2025NMPA Issues Technical Guidelines for Shingles Vaccine Clinical Trials

10/22/2025Zai Lab Launches First Phase 3 Trial of DLL3-Targeted ADC ZL-1310 in R...

10/22/2025GenScript Wins NMPA IND Nod for Bispecific ADC GenSci139

10/21/2025Kelun-Biotech’s Sacituzumab Tirumotecan Shows Strong Phase 3 Results

10/20/2025Akeso Reports Strong China Data for Ivonescimab in Lung Cancer

10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...

10/17/2025LEO Pharma's Anzupgo Cream NDA Accepted in China

10/14/2025GSK's Shingrix Wins Chinese Approval for Expanded Use

10/13/2025Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...

9/23/2025Hangzhou Sciwind Biosciences Files for HKEX Listing

9/19/2025Lilly/Innovent's Mazdutide Approved in China for Type 2 Diabetes Glyce...

9/18/2025On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (C...

9/17/2025CDE Solicits Comments on Draft Guidance for mRNA Vaccine Research

9/17/2025ALK-Abelló Partners with GenSci to Expand Allergy Immunotherapy Marke...

9/13/2025China to Incorporate HPV Vaccines into National Immunization Program

9/9/2025RemeGen's Telitacicept Advances in Sjögren's Syndrome

9/8/2025NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...

9/3/2025Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...

9/3/2025Aon Report Highlights Rapid Growth and Challenges in China's Health In...

8/26/2025Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...

8/22/2025NMPA Approves Domestic Hexavalent Rotavirus Vaccine for Children

8/21/2025Bio-Thera Solutions Taps STADA to Bring BAT1806 to Global Markets

8/21/2025Anixa Secures First Chinese Patent for Breast Cancer Vaccine Technolog...

8/20/2025Pfizer Advances Pneumococcal Vaccine Development in China with Phase 1...

8/20/2025On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (C...

8/14/2025Remegen's Telitacicept Achieves Phase III Success

8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab

8/8/2025Shanghai Unveils 18 New Measures to Boost Commercial Health Insurance ...

8/8/2025Boan's Dulaglutide Biosimilar Secures NMPA Approval in China

Page:1/74 Total number of articles:2211: [First][<<] [1] [2] [3] [4] [5] [>>] [End]